SIGN
Wednesday, 24 May, 2017
The Scottish Intercollegiate Guidelines Network (SIGN) is developing a guideline on the pharmacological management of glucose lowering in people with type 2 diabetes.
The College response makes a number of observations and recommendations relating to various aspects of the draft guideline.
Further information:
